W04-033: EGFR and HERZ/neu expression in feline mammary gland adenocarcinoma and the effects of a novel EGFR inhibitor (Iressa®) on proliferation and apoptosis in vitro
Mammary gland tumors are a common tumor in the cat and most are highly aggressive tumors that will spread throughout the body. Treatment to date has included surgery with or without chemotherapy and/or radiation. However, these treatments have had disappointing results. A new drug, gefitinib (Iressa®), has been efficacious in human breast cancer clinical trials. Significantly fewer side effects occur with this drug than with chemotherapy or radiation therapy. Gefitinib may prove to be a readily available and effective treatment for feline mammary gland adenocarcinoma. In this study, researchers hope to show that gefitinib will be an effective treatment for breast cancer in the cat.
Grant ID: W04-033
Status: Active
Year Funded: 2004
Amount awarded: $10,800
Investigator: Sarah C. Charney, DVM, DACVIM; Anne Barger, DVM, DACVP; Timothy Fan, DVM, DACVIM; L-P de Lorimier, DVM; University of Illinois
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.